NATIONAL BANK OF CANADA /FI/ - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 31 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,099
-90.5%
34,000
-88.8%
0.00%
-100.0%
Q2 2023$559,785
+4290.8%
303,800
+4880.3%
0.00%
Q1 2023$12,749
+52.6%
6,1000.0%0.00%
Q4 2022$8,357
+39.3%
6,1000.0%0.00%
Q3 2022$6,000
-14.3%
6,1000.0%0.00%
Q2 2022$7,000
+16.7%
6,1000.0%0.00%
Q1 2022$6,000
+20.0%
6,100
+1.7%
0.00%
Q4 2021$5,0006,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders